• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

农村河滨地区初级卫生保健团队服务人群接受巴氏涂片宫颈癌筛查的障碍。

Barriers to Access the Pap Smear Test for Cervical Cancer Screening in Rural Riverside Populations Covered by a Fluvial Primary Healthcare Team in the Amazon.

机构信息

Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz, Rua Teresina 476, Manaus 69057-070, Brazil.

Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Av. Carvalho Leal 1777, Manaus 69065-001, Brazil.

出版信息

Int J Environ Res Public Health. 2022 Apr 1;19(7):4193. doi: 10.3390/ijerph19074193.

DOI:10.3390/ijerph19074193
PMID:35409875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998957/
Abstract

Cervical cancer is a major public health problem, especially in the north region of Brazil. The aim of the study was to identify the factors associated with not undergoing the cervical cancer screening test in rural riverside populations in the Amazon. A cross-sectional home-based survey was carried out in 38 locations covered by a fluvial primary healthcare team, and the administrative records of the screening tests from January 2016 to May 2019 were analyzed. After the descriptive analysis, logistic regression was performed considering the outcome of having undergone cervical cancer screening within the past three years. Of the 221 women assessed, 8.1% had never undergone the test, and 7.7% had undergone it more than three years ago. Multiparity (OR = 0.76 (95%CI = 0.64-0.90)), occupation in domestic activities (OR = 0.31 (95%CI = 0.11-0.89)), and lack of knowledge of the healthcare unit responsible for the service (OR = 0.18 (95%CI = 0.04-0.97)) were associated with not undergoing the cervical cancer screening test. The administrative records revealed that the screening test was performed outside the recommended age range (24%), performed needlessly (9.6%) with undue repetitions (3.2%), and a high percentage of the samples collected were unsatisfactory (23.5%). The findings revealed the existence of barriers for riverside women to access cervical cancer screening tests.

摘要

宫颈癌是一个主要的公共卫生问题,尤其是在巴西北部地区。本研究旨在确定与亚马孙地区农村河边人口未接受宫颈癌筛查相关的因素。在由河流水域初级保健团队覆盖的 38 个地点进行了一项基于家庭的横断面调查,并对 2016 年 1 月至 2019 年 5 月期间的筛查测试的行政记录进行了分析。在描述性分析之后,对在过去三年内接受过宫颈癌筛查的结果进行了逻辑回归分析。在所评估的 221 名女性中,8.1%的人从未接受过该检查,7.7%的人在三年前接受过该检查。多胎产(OR = 0.76(95%CI = 0.64-0.90))、从事家务活动的职业(OR = 0.31(95%CI = 0.11-0.89))和缺乏对负责服务的医疗机构的了解(OR = 0.18(95%CI = 0.04-0.97))与未接受宫颈癌筛查测试有关。行政记录显示,筛查测试在推荐年龄范围之外进行(24%),不必要地进行(9.6%)且重复次数过多(3.2%),并且采集的样本中不满意的比例很高(23.5%)。研究结果表明,河边妇女在获得宫颈癌筛查测试方面存在障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861d/8998957/93fd82a3f95d/ijerph-19-04193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861d/8998957/93fd82a3f95d/ijerph-19-04193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/861d/8998957/93fd82a3f95d/ijerph-19-04193-g001.jpg

相似文献

1
Barriers to Access the Pap Smear Test for Cervical Cancer Screening in Rural Riverside Populations Covered by a Fluvial Primary Healthcare Team in the Amazon.农村河滨地区初级卫生保健团队服务人群接受巴氏涂片宫颈癌筛查的障碍。
Int J Environ Res Public Health. 2022 Apr 1;19(7):4193. doi: 10.3390/ijerph19074193.
2
Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.与印度尼西亚农村地区进行巴氏涂片检查意愿相关的因素:健康信念模型。
Reprod Health. 2021 Jun 30;18(1):138. doi: 10.1186/s12978-021-01188-7.
3
Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.流动医疗单位对泰国农村妇女宫颈癌筛查知识及筛查行为变化的影响
Int J Epidemiol. 1995 Jun;24(3):493-8. doi: 10.1093/ije/24.3.493.
4
A mobile unit: an effective service for cervical cancer screening among rural Thai women.一个移动单元:泰国农村妇女宫颈癌筛查的有效服务。
Int J Epidemiol. 1999 Feb;28(1):35-9. doi: 10.1093/ije/28.1.35.
5
Knowledge, Attitudes, and Practices Regarding Cervical Cancer Screening among Omani Women Attending Primary Healthcare Centers in Oman: A Cross-Sectional.阿曼初级保健中心就诊的阿曼妇女对宫颈癌筛查的知识、态度和实践:一项横断面研究。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):775-783. doi: 10.31557/APJCP.2021.22.3.775.
6
Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.土耳其的宫颈癌风险水平及对国家宫颈癌筛查标准的依从性。
Asian Pac J Cancer Prev. 2011;12(4):923-7.
7
Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.阿联酋女性对巴氏涂片检查的了解有限,这成为宫颈癌筛查的障碍。
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3379-3387. doi: 10.22034/APJCP.2017.18.12.3379.
8
Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.影响马来西亚宫颈癌筛查普及率的因素:一项全国性调查。
BMC Womens Health. 2023 Jul 25;23(1):389. doi: 10.1186/s12905-023-02553-3.
9
Evaluation of cervical cancer screening program at a rural community of South Africa.南非一个农村社区宫颈癌筛查项目的评估
East Afr J Public Health. 2008 Aug;5(2):111-6.
10
Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.关于塞尔维亚贝尔格莱德地区宫颈癌、巴氏试验以及女性参与筛查的障碍的知识。
Eur J Gynaecol Oncol. 2017;38(1):69-75.

本文引用的文献

1
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.荷兰常规初级HPV筛查中高危型HPV自我采样与临床医生采样的临床性能:一项观察性研究。
Lancet Reg Health Eur. 2021 Nov 9;11:100235. doi: 10.1016/j.lanepe.2021.100235. eCollection 2021 Dec.
2
Human papillomavirus (HPV) vaccination coverage in Brazil: spatial and age cohort heterogeneity.巴西的人乳头瘤病毒(HPV)疫苗接种覆盖率:空间和年龄队列异质性。
Rev Bras Epidemiol. 2020 Dec 18;24:e210001. doi: 10.1590/1980-549720210001. eCollection 2020.
3
Barriers to access and organization of primary health care services for rural riverside populations in the Amazon.
亚马孙地区农村河畔人口获取和组织初级卫生保健服务的障碍。
Int J Equity Health. 2020 Jul 31;19(1):54. doi: 10.1186/s12939-020-01171-x.
4
Cervical cancer: knowledge, attitude and practice on the prevention examination.宫颈癌:预防检查方面的知识、态度与实践
Rev Bras Enferm. 2019 Dec;72(suppl 3):25-31. doi: 10.1590/0034-7167-2017-0645.
5
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
6
[Access to uterine cervical cytology in a health region: invisible women and vulnerable bodies].[某健康区域子宫颈细胞学检查的可及性:被忽视的女性与脆弱的身体]
Cad Saude Publica. 2019 Oct 7;35(10):e00234618. doi: 10.1590/0102-311X00234618. eCollection 2019.
7
Cervical cancer control limiting factors and facilitators: a literature review.宫颈癌控制的限制因素与促进因素:一项文献综述
Cien Saude Colet. 2019 Sep 9;24(9):3431-3442. doi: 10.1590/1413-81232018249.32592017.
8
Self-collected versus clinician-collected samples for HSV-2 and HSV-2/HPV screening in HIV-infected and -uninfected women in the Tapajós region, Amazon, Brazil.巴西亚马逊地区塔帕若斯河区域HIV感染与未感染女性中用于单纯疱疹病毒2型(HSV - 2)及HSV - 2/人乳头瘤病毒(HPV)筛查的自我采集样本与临床医生采集样本的比较
Int J STD AIDS. 2019 Oct;30(11):1055-1062. doi: 10.1177/0956462419842007. Epub 2019 Aug 27.
9
Evaluation of non-attendance for Pap test through the Surveillance System by telephone survey.通过电话调查,利用监测系统对子宫颈抹片检查未就诊情况进行评估。
Rev Esc Enferm USP. 2018 Nov 23;52(0):e03390. doi: 10.1590/S1980-220X2017029503390.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.